24 related articles for article (PubMed ID: 17637391)
1. An Anti-PSMA Immunotoxin Reduces Mcl-1 and Bcl2A1 and Specifically Induces in Combination with the BAD-Like BH3 Mimetic ABT-737 Apoptosis in Prostate Cancer Cells.
Masilamani AP; Dettmer-Monaco V; Monaco G; Cathomen T; Kuckuck I; Schultze-Seemann S; Huber N; Wolf P
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32580291
[No Abstract] [Full Text] [Related]
2. Tumor-Specific Induction of the Intrinsic Apoptotic Pathway-A New Therapeutic Option for Advanced Prostate Cancer?
Wolf P
Front Oncol; 2019; 9():590. PubMed ID: 31312616
[No Abstract] [Full Text] [Related]
3. Bcl-2 family of proteins as therapeutic targets in genitourinary neoplasms.
Hall C; Troutman SM; Price DK; Figg WD; Kang MH
Clin Genitourin Cancer; 2013 Mar; 11(1):10-9. PubMed ID: 23083798
[TBL] [Abstract][Full Text] [Related]
4. Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1.
Mena S; Rodriguez ML; Ortega A; Priego S; Obrador E; Asensi M; Petschen I; Cerdá M; Brown BD; Estrela JM
J Transl Med; 2012 Jan; 10():8. PubMed ID: 22233801
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of BCL-2 in small cell lung cancer cell lines with oblimersen, an antisense BCL-2 oligodeoxynucleotide (ODN): in vitro and in vivo enhancement of radiation response.
Loriot Y; Mordant P; Brown BD; Bourhis J; Soria JC; Deutsch E
Anticancer Res; 2010 Oct; 30(10):3869-78. PubMed ID: 21036697
[TBL] [Abstract][Full Text] [Related]
6. Combination bcl-2 antisense and radiation therapy for nasopharyngeal cancer.
Yip KW; Mocanu JD; Au PY; Sleep GT; Huang D; Busson P; Yeh WC; Gilbert R; O'Sullivan B; Gullane P; Bastianutto C; Liu FF
Clin Cancer Res; 2005 Nov; 11(22):8131-44. PubMed ID: 16299246
[TBL] [Abstract][Full Text] [Related]
7. Bcl-XL antisense oligonucleotides coupled with antennapedia enhances radiation-induced apoptosis in pancreatic cancer.
Masui T; Hosotani R; Ito D; Kami K; Koizumi M; Mori T; Toyoda E; Nakajima S; Miyamoto Y; Fujimoto K; Doi R
Surgery; 2006 Aug; 140(2):149-60. PubMed ID: 16904964
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
Zhang X; Zhang J; Wang L; Wei H; Tian Z
BMC Cancer; 2007 Aug; 7():149. PubMed ID: 17683579
[TBL] [Abstract][Full Text] [Related]
9. Sodium selenite radiosensitizes hormone-refractory prostate cancer xenograft tumors but not intestinal crypt cells in vivo.
Tian J; Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):230-6. PubMed ID: 20615620
[TBL] [Abstract][Full Text] [Related]
10. Irradiation of human prostate cancer cells increases uptake of antisense oligodeoxynucleotide.
Anai S; Brown BD; Nakamura K; Goodison S; Hirao Y; Rosser CJ
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1161-8. PubMed ID: 17637391
[TBL] [Abstract][Full Text] [Related]
11. Antisense oligodeoxynucleotide therapy targeting clusterin gene for prostate cancer: Vancouver experience from discovery to clinic.
Miyake H; Hara I; Gleave ME
Int J Urol; 2005 Sep; 12(9):785-94. PubMed ID: 16201973
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of antisense analogues in the central nervous system.
Szklarczyk A; Kaczmarek L
Neurochem Int; 1997 Sep; 31(3):413-23. PubMed ID: 9246683
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
